Large global study links higher alcohol intake to increased pancreatic cancer risk

Drinking more alcohol, especially beer or liquor, modestly raises your risk of pancreatic cancer, according to one of the world’s largest and most comprehensive studies. Study: Alcohol intake and pancreatic cancer risk: An analysis from 30 prospective studies across Asia, Australia, Europe, and North America. Image Credit: crystal light / Shutterstock The analysis of a large-scale dataset … Read more

GLP-1s Lower Pancreatitis Complications, Mortality in T2D

TOPLINE: Patients with type 2 diabetes (T2D) who received glucagon-like peptide 1 (GLP-1) receptor agonists had a significantly lower risk of developing local or systemic complications — even if they developed acute pancreatitis — and showed more than a 50% reduction in risk for all-cause mortality than those who did not receive these medications. METHODOLOGY: … Read more

High Readmission Rates in Necrotizing Pancreatitis

TOPLINE: Almost one fifth of patients hospitalized for necrotizing pancreatitis (NP) will be readmitted within 30 days, with biliary and idiopathic pancreatitis carrying higher risk than alcohol-induced disease, according to a new study. METHODOLOGY: NP is associated with a significant healthcare burden, including hospital admission, but few studies have evaluated readmission rates of NP. Researchers … Read more

Impact of excessive alcohol consumption on digestive health

Excessive alcohol consumption is a significant public health concern, responsible for approximately 6% of all deaths and contributing to 5.1% of the global disease burden. Alcohol use is a major risk factor for over 200 diseases, including liver cirrhosis, pancreatitis, and esophageal cancer, with a particularly high incidence of gastrointestinal diseases. More than 50% of … Read more

Considerations for Prescribing GLP-1s Get More Complicated

We know now that glucagon-like peptide 1 (GLP-1) drugs for obesity bring with them a whole host of other potential benefits, as well as a handful of side effects. But new research has brought a sharper focus on both the pros and the cons of these medications, and with that comes new challenges and opportunities … Read more

What a Doctor Wants You to Know: Essential Health Tips You Can’t Ignore

The most Dangerous Ozempic ⁢Side ⁤Effects: What ⁢You Need to Know ‍ When it comes​ to weight ‍loss adn diabetes management, ⁤ GLP-1 ‍receptor agonist ⁣medications ⁤like Ozempic and Wegovy have become household names. ‍While these drugs are celebrated‌ for their effectiveness, a new study sheds light on‌ their darker‍ side—perhaps severe side effects that … Read more